Medicines Reimagined:
Unlocking the Potential of Existing Drugs for Patient Benefit
Amsterdam
The Netherlands
INTERNATIONAL DRUG REPURPOSING CONFERENCE
Join us at iDR25 – the international drug repurposing conference – to unlock the full potential of medicines by driving innovation for patient benefit. From cutting-edge AI approaches transforming drug discovery to exploring innovative business models and regulatory pathways for market access. The event brings together key opinion leaders from research and patient communities, policymakers, funders, regulators and the private sector. Discover how funders are shaping the future of drug repurposing and explore real-life examples. Join others who are passionate about the transformative potential of medicines, to innovate, connect and reshape drug repurposing.
CONFERENCE STARTS IN:
Why join this event?
Connect with global experts and key opinion leaders and learn first-hand why and how drug repurposing is fast evolving to revolutionise the medicine development landscape.
What to expect from iDR25?
Learn from real-life examples
Hear from those at the forefront of successful drug repurposing initiatives and discover how cutting-edge AI and patient-centric trial designs are redefining clinical research.
Drive Policy Change and Shape the Future of Healthcare
Explore the potential impact of drug repurposing on public health, gain valuable insights on regulatory pathways, and learn about policy advancements crucial to facilitate patient access to medicines.
Grow Your Network
Interact with diverse stakeholders from across the drug repurposing pipeline through dedicated sessions and partnering opportunities to strengthen existing collaboration and foster new connections.
Explore Viable Business Models with Key Stakeholders
Identify innovative business models that cultivate cross-sectoral benefits.
Who is it for?
PATIENTS
Organisations – Patient champions
RESEARCHERS
Academia – Clinical – Industry – Early Career Researchers
INDUSTRY
Big pharma – Generics – Biotech – SMEs
FUNDERS
Funding programmes – Philanthropic organizations – Payers
IMPACT INVESTORS
POLICY MAKERS & PAYERS
REGULATORY BODIES & HTAs
RESEARCH INFRAESTRUCTURES & SERVICE PROVIDERS
Interactive pre-conference workshop
To kick-off iDR25 we will be hosting an inspiring pre-conference half-day workshop in Amsterdam on 6th May.
Register your interest today and stay tuned for updates coming soon.
CONFERENCE AGENDA
Full conference agenda to follow soon but to include insightful plenaries, fruitful discussions and expert speakers in the fields of AI in clinical decision-making and discovering new drug repurposing opportunities; helping to treat underserved populations: repurposing drugs for rare diseases, rare cancers, children and rare infectious conditions; innovative trial designs and repurposing policy and pathways to patient access.
Ticketing
There are three different ticket types for this conference. If you are unsure what is your ticket group, please email conference@remedi4all.org.
We appreciate there may be a financial-barrier to small patient groups and patients in attending this conference. We hope to be able to support these individuals in attending where possible. Please get in touch with conference@remedi4all.org to discuss your needs.
Cancellation policy: All cancellations must be received in writing to conference@remedi4all.org 15 calendar days prior to the start of the event (28 April 2025) and will be subject to an administration fee of the ticketing platform. For cancellation after this time – or if the delegate fails to attend the event- no refund of fees may be expected and the amount of the invoice is due. Substitutions are welcome at no extra charge but only until 9 May 2025.
Early Bird Tickets
General Admission
This is the most common ticket. Unless you belong to one of the groups listed below, this is the ticket you should select.
€450
Regular price: €590
Early Bird Tickets
Academia, Clinicians, Regulatory & Government
This ticket is reserved for clinicians, academics, scientists, HTAs, regulatory and government bodies.
€230
Regular price: €320
Early Bird Tickets
Patients & Charities
This ticket is reserved for patient organisations, patients, patient caregivers, and charities.
€95
Regular price: €120
Sponsorship opportunities
Interested in becoming a sponsor of this event?
Showcase your business to a diverse audience, including researchers, the patient community, funders, regulators, and representatives from the private sector. As a sponsor, you'll get unique visibility through strategic logo placements, exhibition space, social media exposure, networking opportunities, and more. Contact our sponsorship team at sponsorship@remedi4all.org to find out more about the various sponsorship packages available.
Contact sponsorship teamFelix Meritis
The international drug repurposing conference “Medicines Reimagined: Unlocking the Potential of Existing Drugs for Patient Benefit” will take place at Felix Meritis (Amsterdam) between 7-8 May 2025-
Felix Meritis, an icon on the Keizersgracht, was established in 1777 as a society of entrepreneurs, scientists, artists, and philosophers. With seven magnificent halls, including the impressive Concertzaal and the renowned Shaffyzaal with balcony and foyer. The decor pays homage to its illustrious past, while the facilities are state-of-the-art for the 21st century.
Felix Meritis
Keizersgracht 324
1016 EZ Amsterdam
The Netherlands
Stay in one of the many hotels nearby
Co-organisers
REMEDi4ALL
REMEDi4ALL is an EU-funded research initiative that is driving forward the repurposing of medicines in Europe.
Beacon for rare diseases
Beacon is a UK-based charity that is building a united rare disease community with patient groups at its heart.
Headline Sponsor
ZonMw
ZonMw programmes and funds research and innovation in health, healthcare and well-being, encourages the use of this knowledge and highlights knowledge needs.
REMEDi4ALL Partners & Associated partners
Interested in joining this event? Subscribe to the newsletter
We will keep you updated on the event. You can unsubscribe at any time.
